###### Strengths and limitations of this study

-   Comprehensive synthesis of the current evidence on diagnostic accuracy of selective nerve root block (SNRB) in lumbar radiculopathy.

-   Extensive literature searches were conducted using several databases without restrictions on publication date, language or study type, in an attempt to locate all relevant studies.

-   We used rigorous eligibility criteria, which excluded studies with mixed cervical and lumbar spine pathology and studies where there was insufficient data to construct estimates of sensitivity and specificity.

-   Only a small number of primary diagnostic accuracy studies could be included in our review and all had methodological limitations.

-   Due to the small number of studies, we were unable to explore the value of SNRB in potentially important patient subgroups, such as those with suspected multilevel radiculopathy.

Introduction {#s1}
============

In Western Europe, low back pain is the leading cause of disability and represents a high economic burden,[@R1] in particular due to production losses and cost of informal care.[@R1] In a subgroup of patients, low back pain is accompanied by pain radiating to a lower extremity in a radicular distribution (sciatic pain). Leg pain is one of the symptoms of lumbar radiculopathy (LR) but other symptoms, such as numbness, tingling, weakness, can also develop. LR can be the result of compressive or inflammatory disorders of the spinal nerve roots or a combination of these. Randomised trial evidence on the effectiveness of lumbar decompressive surgery in patients with radiculopathy and intervertebral disc herniation suggests that early surgery leads to faster pain relief, but longer-term effectiveness is less clear.[@R2] Current UK guidelines recommend spinal decompression surgery for patients with radicular pain when non-surgical treatments have not improved symptoms and radiological findings are consistent with physical examination.[@R8] However, surgery does not always resolve radicular pain and 5%--36% of patients suffer from recurrent back and leg pain within 2 years postsurgery.[@R9] The main cause of unsuccessful back surgery is inaccurate diagnosis.[@R10] Improved diagnosis could help identify patients most likely to benefit from surgery and minimise the cost and risks associated with unsuccessful back surgery.

A timely and accurate diagnosis of the cause of low back pain and radicular pain is important, since it is occasionally an early symptom of serious systemic disease,[@R11] and an inaccurate diagnosis can lead to a cascade of costly, invasive and ineffective therapy. In most patients, the diagnosis of radiculopathy, caused by nerve root compression, is made by correlation of symptoms, clinical signs and imaging findings. However, neither clinical findings nor radiological imaging have perfect diagnostic accuracy.[@R12] When clinical and imaging findings are equivocal or discordant, uncertainty remains about the source of the symptoms and whether nerve root decompression will relieve symptoms. Additional diagnostic tests could help clinicians and patients to choose between surgical and conservative care or guide surgery in patients with suspected multilevel radiculopathy.

Diagnostic selective nerve root blocks (SNRBs) inject local anaesthetic or other substances around spinal nerves under imaging guidance. Both provocative responses (replicating symptoms during needle placement) and analgesic responses (significant reduction of symptoms) to SNRB may be diagnostically useful in confirming or ruling out a given nerve root as the source of clinical symptoms. Some clinical guidelines and consensus statements have endorsed the use of SNRB to identify the source of pain in patients with multilevel pathology and in the preoperative evaluation of patients with a negative or inconclusive imaging study.[@R13] Over the last decade, several systematic reviews have investigated SNRB as diagnostic tool, covering the literature up to 2012.[@R15] However, evidence was scarce and of low quality and the diagnostic accuracy and reliability of SNRB remained unclear. We updated our previous systematic review to determine the diagnostic performance of SNRB in addition to clinical and imaging findings for identifying patients with LR who are good candidates for lumbar decompression surgery.[@R15] A secondary aim was to summarise evidence on the incidence of procedure-related complications.

Materials and methods {#s2}
=====================

Literature search {#s2a}
-----------------

We updated the search from our previous review, searching all databases to March 2018. Our previous search aimed to identify published and unpublished studies by searching MEDLINE (Ovid), MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, Science Citation Index, Biosis and LILACS (Latin American and Caribbean literature database), Dissertation abstracts and National Technical Information Servicefrom inception to March 2018. Our search strategy combined terms for SNRB with terms for sciatica or radiculopathy (see online [supplementary search strategy](#SP1){ref-type="supplementary-material"}).[@R15] We did not use a methodological search filter to identify diagnostic accuracy studies as such filters result in the omission of relevant studies.[@R19] No language restrictions were applied. Attempts were made to identify further studies by examining the reference lists of all included articles.
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Study selection {#s2b}
---------------

Studies were eligible for the diagnostic accuracy review if they included patients with low back pain and leg pain who underwent SNRB under imaging guidance. The studies needed to report sufficient data to construct a table detailing diagnostic accuracy (ie, numbers of true negative, true positive, false positive and false negative results) of the index test (SNRB) compared with any reported 'reference standard'. When we were unable to extract sufficient details from otherwise eligible studies we contacted study authors.

In diagnostic accuracy studies, the reference standard is typically a definitive test used to determine the true diagnosis, but no such definitive test exists for radicular pain due to nerve root compression. Therefore, most diagnostic studies used either intraoperative findings or postsurgical follow-up as the reference standard to judge the diagnostic accuracy of SNRB. An alternative approach is to determine the sensitivity of SNRB using a 'case' injection at a symptomatic nerve root level where nerve root compression is confirmed by imaging. Specificity is evaluated by a 'control' injection at an asymptomatic site (eg, adjacent nerve root) where imaging demonstrates no nerve root compression. Hence, in this approach, concordant clinical and imaging findings are used as the reference standard.

Two reviewers independently screened titles and abstracts for relevance and full papers for eligibility. Any disagreements were resolved by consensus or referred to the review team.

Data extraction and quality (bias and applicability) assessment {#s2c}
---------------------------------------------------------------

Data extraction was performed by one reviewer and checked by a second: disagreements were resolved by consensus or discussion among coauthors. We extracted data on: study design, inclusion and exclusion criteria, included patients, SNRB details and reference standard details. 'Per patient' data were extracted: if these were unavailable we extracted 'per injection' data.

Studies included in the diagnostic review were assessed for methodological quality using the QUADAS-2 measure of bias and applicability.[@R16] Bias occurs if the results of a study are distorted by flaws or limitations in its design or conduct (eg, knowledge of the index test result when interpreting the reference standard). Applicability may be reduced if patient characteristics, or the use or interpretation of the index test in the study differ from those likely to prevail in clinical practice. Reviewers rate concerns regarding applicability and risk of bias as low, high or unclear. At least two reviewers assessed quality using QUADAS-2 and any disagreements were resolved by consensus.[@R22]

Studies were judged to be of high applicability if: (1) they recruited patients with low back pain and suspected radiculopathy (sciatica) with non-congruent imaging and clinical findings, who might benefit from lumbar decompression surgery; (2) the SNRB included injection of anaesthetic, sometimes in conjunction with a steroid, close to the lumbar nerve root most often under guidance by fluoroscopy or other imaging; (3) the test aimed to identify patients with radiculopathy (sciatica) that was amenable to surgery and (4) the reference standard was outcome of surgery. We did not carry out formal quality assessment of studies reporting on adverse events.

Data synthesis and analysis {#s2d}
---------------------------

We performed all analyses in Stata V.15.1.[@R23] We calculated sensitivity and specificity of SNRB from each study and plotted these in receiver-operating characteristic space. We performed random-effects logistic regression to meta-analyse studies grouped by reference standard,[@R24] using an updated version of the *metandi* package.[@R25] Data from studies on adverse events were combined in a narrative summary. We reported our findings according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysesfor diagnostic test accuracy studies.[@R26]

Patient and public involvement {#s2e}
------------------------------

Patients and members of the public were not involved in this review.

Results {#s3}
=======

The original searches identified 12 883 titles and abstracts and an additional 5267 were identified in the update search in 2018. Overall, 61 titles and abstracts were considered potentially relevant and full papers were retrieved and screened. Our original review included five studies. We identified one additional relevant study through our updated searches. A total of six studies (total 341 patients, sample size range 15--100) were therefore included in the review of diagnostic accuracy ([figure 1](#F1){ref-type="fig"}). Where reported, the mean age of patients was in the mid-forties, the majority were male, and most had had symptoms for at least 3 months. One study excluded patients with a previous history of lumbar surgery,[@R27] in contrast a substantial minority of patients (up to 48%) had had previous surgery in two of the other studies. Details of the patients included, and the injections delivered in each study are given in [table 1](#T1){ref-type="table"} (online [supplementary table 1](#SP2){ref-type="supplementary-material"}).
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![Flowchart of diagnostic study selection process. SNRB, selective nerve root block.](bmjopen-2018-025790f01){#F1}

###### 

Details of included studies

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author (year) country                     N analysed/N recruited   Description of included patients                                                                                                              Details of previous surgery                                       Needle level         Anaesthetic details                               Guided method          Needle provocation   Number of control injections   Time to pain measurement
  ----------------------------------------- ------------------------ --------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------- -------------------- ------------------------------------------------- ---------------------- -------------------- ------------------------------ --------------------------
  Within-patient case--control studies                                                                                                                                                                                                                                                                                                                                                                                                 

   Yeom *et al* [@R27] (2008)\              47/83                    Established single-level radiculopathy.\                                                                                                      No history of lumbar surgeries                                    L3, L4, L5, S1       1 mL of 2% lidocaine                              Fluoroscopy            No                   1 or 2                         30 min
   NR                                                                Concordant imaging and clinical findings                                                                                                                                                                                                                                                                                                                          

   North *et al* [@R32] (1996) USA          33/33                    Established sciatica with or without low back pain. History of nerve root compression or imaging findings of ongoing nerve root compression   48% history of root compression corrected surgically              L5, S1               3 mL of 0.5% bupivacaine                          Fluoroscopy            Yes                  3                              Every 15 min for 3 hours

  Prospective diagnostic cohort studies                                                                                                                                                                                                                                                                                                                                                                                                

   Schutz *et al* [@R28] (1973) Canada      15/23                    Current sciatica symptoms                                                                                                                     Unclear if patients included in analysis had previous surgeries   NR                   1 mL of procaine (concentration NR)               Guided but method NR   Yes                  1 or 2                         Immediate

  Retrospective diagnostic cohort studies                                                                                                                                                                                                                                                                                                                                                                                              

    Sasso *et al* [@R31]\                   83/83                    Cervical or lumbar radiculopathy.\                                                                                                            Unclear how many previous lumbar surgeries                        NR                   0.5--0.7 mL of 2% lidocaine                       Fluoroscopy            Yes                  NR                             Immediate
    (2005) USA                                                       Discordant imaging and clinical findings                                                                                                                                                                                                                                                                                                                          

   Dooley *et al* [@R29] (1988) Canada      62/73                    Radicular pain and previous nerve root infiltration                                                                                           32≥1 previous surgery, 3 had 4surgeries                           L3, L4, L5, S1       1 mL of 1% mepivacaine or lidocaine               Fluoroscopy            Yes                  NR                             Immediate

   Williams *et al* [@R30] (2015) UK        96/100                   Presumed radicular leg pain.\                                                                                                                 NR                                                                L1, L3, L4, L5, S1   2 mL of 1% lidocaine and 0.5--1 mL of Iopamidol   Fluoroscopy            Yes                  NR                             Immediate
                                                                     Discordant clinical and imaging findings                                                                                                                                                                                                                                                                                                                          
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DRGB, dorsal root ganglion block; NR, not reported; SNRB, selective nerve root block.

Four diagnostic cohort studies (one prospective and three retrospective) recruited patients with suspected LR in whom some doubt remained due to equivocal or discordant clinical and radiological findings. Schutz *et al* and Dooley *et al* used intraoperative findings during surgery as the reference standard ([table 2](#T2){ref-type="table"}).[@R28] In addition, Dooley *et al* used outcome following surgery as a second reference standard.[@R29] Williams and Germon and Sasso *et al* used outcome following surgery at 3 and 12 months,[@R30] respectively, as the reference standard.

###### 

Diagnostic accuracy results

  Author (year)                                               Threshold                                                                Reference standard                                                                                                                                 TP              FN   Sensitivity % (95% CI)   TN             FP                 Specificity % (95% CI)   PLR (95% CI)        NLR (95% CI)
  ----------------------------------------------------------- ------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ---- ------------------------ -------------- ------------------ ------------------------ ------------------- ------------------
  Within-patient case-control studies\*                                                                                                                                                                                                                                                                                                                                                                                
   Yeom *et al* [@R27] (2008)                                 70% pain relief---several other thresholds also evaluated                Concordant symptoms and imaging evidence of compression (case injections) or no symptoms or imaging evidence of compression (control injections)   27              20   57 (43 to 70)            50             8                  86 (75 to 93)            4.1 (2.1 to 8.3)    0.5 (0.4 to 0.7)
   North *et al* [@R32] (1996)                                50% reduction in baseline pain following block                           Concordant symptoms and imaging evidence of compression (case injections) or no symptoms or imaging evidence of compression (control injections)   30              3    91 (76 to 97)            8              25                 24 (12 to 41)            1.2 (1.0 to 1.5)    0.4 (0.1 to 1.3)
  Diagnostic cohort studies                                                                                                                                                                                                                                                                                                                                                                                            
   Schutz *et al* [@R28] (1973)                               100% pain relief. Full trunk flexion and straight leg raising possible   Intraoperative findings                                                                                                                            12              0    100 (76 to 100)          1              2                  33 (6 to 79)             1.5 (0.7 to 3.3)    0.0
   Sasso *et al* [@R31] (2005)                                Visual Analogue Scale score 0--1 and immediate relief of \>95% pain      Outcome 12 months following surgery                                                                                                                71              3    96 (89 to 99)            5              4                  56 (27 to 81)            2.2 (1.0 to 4.5)    0.1 (0.0 to 0.3)
   Dooley *et al* [@R29] (1988)                               Pain relief                                                              Intraoperative surgical confirmation of root pathology                                                                                             46              4    92 (81 to 98)            2              1                  67 (9 to 99)             2.8 (0.6 to 13.7)   0.1 (0.0 to 0.4)
  Outcome following surgery (follow-up range 24--36 months)   28                                                                       4                                                                                                                                                  88 (71 to 96)   2    19                       10 (1 to 30)   1.0 (0.8 to 1.2)   1.2 (0.3 to 6.5)                             
   Williams *et al* [@R30] (2015)                             Pain relief                                                              Outcome 3 months following surgery (resolution of symptoms)                                                                                        41              7    85 (72 to 94)            2              10                 17 (3 to 48)             1.0 (0.8 to 1.4)    0.9 (0.2 to 3.7)

\*Please note that the unit used in the within-patient case--control studies is number of injections and some patients had two control injections at adjacent levels in addition to the affected nerve; in all other studies it is number of patients.

FN, false negative; FP, false positive; NLR, negative likelihood ratio; PLR, positive likelihood ratio; TN, true negative; TP, true positive.

Two studies had a within-patient case-control study design. In the Yeom *et al* study, control injections were given at adjacent asymptomatic nerve roots,[@R27] whereas in the North *et al* study, other anatomic sites in the lumbar spine were injected (sciatic nerve, facet joint and subcutaneous).[@R32] All cases were confirmed by concordant clinical and radiological or surgical findings prior to the use of SNRB.

Quality of included studies {#s3a}
---------------------------

All studies were judged at high risk of bias ([table 3](#T3){ref-type="table"}). All studies had high risk of bias for the reference standard because postsurgical outcomes were not considered[@R27] or selectively measured[@R28] (eg, surgery was predominantly performed in patients with positive SNRB findings). The four cohort studies were at high risk of bias for flow and timing because patients were selected to undergo surgery based on the SNRB result, with patients testing positive more likely to receive surgery. It is likely that the patients with negative SNRB results who, despite this, were selected for surgery were a biased subset of those testing negative as these are likely to have been the patients in whom the clinicians suspected a false negative result. The two within-patient case-control studies were at high risk of bias and poor applicability for patient selection because they recruited patients with unequivocal and concordant imaging and clinical findings rather than patients where diagnostic uncertainty remained. Three cohort studies were judged as low concerns regarding applicability on all domains.[@R29] There were high concerns regarding the applicability of the fourth cohort study as the reference standard consisted of intraoperative findings alone.[@R28]

###### 

QUADAS-2 results

  Author (year)                         Risk of bias                        Applicability concerns                                                                                                                                                              
  ------------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ----------------------------------- -----------------------------------
  Within-patient case-control studies                                                                                                                                                                                                                           
   Yeom *et al* [@R27] (2008)           ![](bmjopen-2018-025790ilf05.jpg)   ![](bmjopen-2018-025790ilf04.jpg)   ![](bmjopen-2018-025790ilf14.jpg)   ![](bmjopen-2018-025790ilf10.jpg)   ![](bmjopen-2018-025790ilf01.jpg)   ![](bmjopen-2018-025790ilf11.jpg)   ![](bmjopen-2018-025790ilf03.jpg)
   North *et al* [@R32] (1996)          ![](bmjopen-2018-025790ilf17.jpg)   ![](bmjopen-2018-025790ilf15.jpg)   ![](bmjopen-2018-025790ilf07.jpg)   ![](bmjopen-2018-025790ilf06.jpg)   ![](bmjopen-2018-025790ilf02.jpg)   ![](bmjopen-2018-025790ilf13.jpg)   ![](bmjopen-2018-025790ilf29.jpg)
  Diagnostic cohort studies                                                                                                                                                                                                                                     
   Sasso *et al* [@R31] (2005)          ![](bmjopen-2018-025790ilf09.jpg)   ![](bmjopen-2018-025790ilf19.jpg)   ![](bmjopen-2018-025790ilf26.jpg)   ![](bmjopen-2018-025790ilf23.jpg)   ![](bmjopen-2018-025790ilf20.jpg)   ![](bmjopen-2018-025790ilf28.jpg)   ![](bmjopen-2018-025790ilf16.jpg)
   Schutz *et al* [@R28] (1973)         **?**                               ![](bmjopen-2018-025790ilf32.jpg)   ![](bmjopen-2018-025790ilf08.jpg)   ![](bmjopen-2018-025790ilf18.jpg)   **?**                               ![](bmjopen-2018-025790ilf27.jpg)   ![](bmjopen-2018-025790ilf12.jpg)
   Dooley *et al* [@R29] (1988)         ![](bmjopen-2018-025790ilf22.jpg)   ![](bmjopen-2018-025790ilf21.jpg)   ![](bmjopen-2018-025790ilf24.jpg)   ![](bmjopen-2018-025790ilf35.jpg)   ![](bmjopen-2018-025790ilf31.jpg)   ![](bmjopen-2018-025790ilf34.jpg)   ![](bmjopen-2018-025790ilf33.jpg)
   Williams *et al* [@R30] (2015)       ![](bmjopen-2018-025790ilf25.jpg)   **?**                               ![](bmjopen-2018-025790ilf36.jpg)   ![](bmjopen-2018-025790ilf40.jpg)   ![](bmjopen-2018-025790ilf38.jpg)   ![](bmjopen-2018-025790ilf37.jpg)   ![](bmjopen-2018-025790ilf41.jpg)

![](bmjopen-2018-025790ilf30.jpg), low risk/concern; ![](bmjopen-2018-025790ilf39.jpg), high risk/concern; ?, unclear risk/concern.

Summary of test accuracy results {#s3b}
--------------------------------

The diagnostic cohort studies reported data at the patient level, but only data at the injection level were available for the within-patient case-control studies. The threshold used to determine a positive SNRB test varied between studies ([table 2](#T2){ref-type="table"}). We decided not to pool the results of studies that used different reference standards.

There was substantial heterogeneity in estimates of sensitivity and specificity across studies; sensitivity ranged from 57% to 100% and specificity from 10% to 86% ([table 2](#T2){ref-type="table"}, [figure 2](#F2){ref-type="fig"}). Sensitivity exceeded 85% in all studies except Yeom *et al* (57%).[@R27] Specificity was lower than 75% in all studies except Yeom *et al* (86%).[@R27] Interpretation of specificity is particularly hampered by verification bias in the cohort studies. Because surgeons were not blinded to the SNRB results, very few patients with negative test findings had surgery. Williams and Germon, Sasso *et al*, Schutz *et al* and Dooley *et al* contributed a total of just 10 true negative cases.[@R28] The higher specificity reported by Yeom *et al* could be a manifestation of patient selection bias as 'control' injections were performed at a level of the spine where the patients had no symptoms or imaging findings suggestive of pathology.[@R27] Positive likelihood ratios were generally low (\<5), meaning that a positive SNRB result did not greatly increase the posttest probability that the nerve root was the source of the low back and radicular pain.

![ROC plot displaying diagnostic accuracy results of included studies. CI, control injection reference standard; IO, intraoperative reference standard; PS, postsurgical reference standard; ROC, receiver-operating characteristic.](bmjopen-2018-025790f02){#F2}

Due to the patient selection bias inherent in within-patient case-control designs, we decided that it would be inappropriate statistically to combine their results with those of the diagnostic cohort studies, and because of differences in the type of control injection we did not pool the results of the two studies. Based on the two cohort studies that used an intraoperative reference standard the pooled sensitivity was 93.5% (95% CI 84.0% to 97.6%) and specificity was 50.0% (16.8% to 83.2%). For the three studies that used postsurgery as the reference standard, the summary sensitivity was 90.9% (83.1% to 95.3%) and summary specificity was 22.0% (7.4% to 49.9%). Low specificity implies that a high proportion of patients without nerve root compromise have a positive SNRB result.

Adverse events review {#s3c}
---------------------

Eight studies assessed complications and/or adverse events (online [supplementary table 2](#SP3){ref-type="supplementary-material"}).[@R28] Two were diagnostic cohorts,[@R28] one was a randomised controlled trial[@R34] and five were case series.[@R33] Only one reported the complications of SNRBs in the lumbar spine as the primary outcome.[@R33] Five studies reported that there were no complications. Tajima *et al* reported aggravated pain in the lower extremity for 1--2 days following selective radiculography and block in 4 (3.8%) patients.[@R38] The largest study reported that minor and transient complications were encountered in 98 of the 1777 total patient visits (during which 2217 injections were delivered to 1203 patients), giving an overall per patient visit complication rate of 5.5%.[@R33] Complications occurred in 134 of the 2217 total injections (6% complication rate per injection). There were no major or permanent complications resulting from SNRB in this large case series.
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Discussion {#s4}
==========

Despite the long-standing use of SNRB to help in the selection of patients who might benefit from surgery and in guiding the surgical approach, few studies have estimated its diagnostic accuracy. Our systematic review identified six studies, all at high risk of bias. Many were at risk of verification bias, because patients with positive SNRB were more likely to undergo surgery than those testing negative. There was substantial variation in estimates of sensitivity and specificity across studies. Based on the three cohort studies that used postsurgery outcomes as the reference standard, the summary sensitivity was 90.9% (83.1% to 95.3%) and summary specificity was 22.0% (7.4% to 49.9%). SNRB is a safe test with a low risk of clinically significant complications, but it remains unclear whether the additional diagnostic information it provides, improves patient outcomes or justifies the cost of the test.

Extensive literature searches were conducted in an attempt to locate all relevant studies. These included electronic searches in a wide variety of databases, scanning the references of included studies and previous systematic reviews. Diagnostic accuracy studies are difficult to identify from electronic databases as there are no specific indexing terms. Therefore, very sensitive searches were carried out to ensure that relevant studies were not missed. It is unlikely that any relevant published studies have been missed, although it is possible that some unpublished studies were not identified. The small number of primary diagnostic accuracy studies included in our review, all had methodological limitations. Due to the small number of studies, we were unable to explore the value of SNRB in potentially important patient subgroups, such as those with suspected multilevel radiculopathy.

Four previous systematic reviews of the diagnostic utility of SNRB in patients whose pain was of spinal origin have been reported.[@R15] The two earlier reviews had positive interpretations of the data and concluded that there was moderate evidence for SNRB in the 'pre-operative evaluation of patients with negative or inconclusive imaging studies, but with clinical findings of nerve root irritation'.[@R16] More recent reviews, however, concluded that there was limited evidence for the accuracy of SNRB as a diagnostic tool.[@R15] Our update review shows similar results. We found limited evidence which was of low methodological quality indicating that the diagnostic accuracy of SNRB is uncertain and that specificity in particular may be low. The differences in interpretation between our review and those conducted previously may be partly due to the smaller number of primary studies included in our review. We used rigorous eligibility criteria, which excluded studies with mixed cervical and lumbar spine pathology and studies where there was insufficient data to construct estimates of sensitivity and specificity.

For centres that currently rely on SNRB for diagnostic information to help decide whether, or at which level, to perform lumbar decompressive surgery, it is vital that better evidence is generated. Moreover, according to Hospital Episodes Statistics (HES), which contains records of all admissions, appointments and attendances for patients at NHS hospitals in England, 58 399 injections of therapeutic substance around spinal nerve root took place from 1 April 2016 to 31 March 2017.[@R8] Due to the granularity of HES data, it is not possible to tell how many of these injections were diagnostic lumbar SNRB. Nevertheless, the number is substantial, and it is therefore apparent that the community of spinal surgeons has a responsibility to generate robust evidence for the use of diagnostic SNRBs. A methodologically ideal diagnostic accuracy study is unlikely to be clinically acceptable as it would require all patients, including those with negative SNRB findings, to undergo surgery. Furthermore, while diagnostic accuracy studies can explore whether SNRB accurately predicts surgical outcomes, they cannot answer the more fundamental question of whether SNRB improves surgical decisions and patient outcomes. Much better evidence would be provided by a trial randomising patients who are being considered for surgery but have discordant or equivocal clinical and imaging findings of nerve root compression to receive a diagnostic SNRB or to have management based on clinical and imaging findings alone. Given the lack of high quality evidence on the diagnostic accuracy of SNRB, we believe that such a trial would be ethically acceptable and would help patients, clinicians and healthcare payers decide whether SNRB can improve patient outcomes by targeting surgery at those most likely to benefit.

Finally, it should be mentioned that this systematic review did not consider the use of SNRBs as a therapeutic option for patients with radicular pain due to a prolapsed lumbar intervertebral disc. The most recent National Institute for Heath and Care Excellence (NICE) guidance concluded that the evidence for both image guided and non-image guided injections for patients with acute and severe sciatica was mostly low or moderate.[@R8] However, the guidance recommends that an injection of local anaesthetic and steroid should be considered in acute, severe sciatica where patients would otherwise be offered surgery. The NErve Root Block VErsus Surgery (NERVES) randomised trial, which enrolled patients in 12 NHS hospitals, aimed to compare surgical microdiscectomy versus SNRB in patients with sciatica of at least 6 weeks' duration secondary to a prolapsed intervertebral disc. The results of this trial, which is currently in follow-up, will elucidate the role of SNRB as a therapeutic but not diagnostic option. Hence, it is important that consideration is given to a trial of diagnostic SNRB as outlined above.

Conclusions {#s5}
===========

There is no high-quality evidence on the diagnostic accuracy of SNRB in patients with radiculopathy and discordant or equivocal imaging findings. The evidence that is available suggests that the specificity of SNRB is low. As there is no adequate reference standard for determining the diagnostic accuracy of SNRB, future research should focus on randomised controlled trials to evaluate whether SNRB improves the process of care or patient outcomes.
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